Immuno-Oncology 2014: Programme

The interaction between the immune system and cancer cells has long been recognised. Immuno-Oncology 2014 will examine new exciting therapeutic possibilities for patients from recent clinical trials. 

Download the Preliminary Programme  

Conference objectives

  • To provide an essential update to oncology professionals on the role of the immune system in malignant diseases
  • To present the latest achievements in immuno-oncology research across range of haematologic and solid tumours
  • To elaborate on different emerging issues in immuno-oncology research 
  • To critically discuss perspective of different therapeutic strategies in the field of immuno-oncology

Major themes

  • Immunotherapy advances in haematological malignancies
  • Cancer antigens – new horizons 
  • T-cell engineering
  • Immune checkpoint blockade
  • Immuno-Oncology clinical studies across tumour types

ESMO-MORA accreditation

The Symposium programme has been submitted for ESMO-MORA category 1 points accreditation. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. Find out more about ESMO-MORA accreditation.

CME accreditation

The Symposium programme will be submitted for accreditation to the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Find out how to convert EACCME credit to AMA credit.

Travel grants

A restricted number of travel grants to the Symposium will be available. Travel grant recipients will be selected by the Scientific Committee.

To apply for a travel grant the following documents are to be received by the Immmuno-Oncology Symposium Secretariat by Friday, 3 October 2014.

  • A letter of introduction by the applicant. Please include the following general information:
    • How relevant are the topics presented during this Symposium to your current practice and research?
    • Have you attended any event on a similar topic in the last 3 years?
    • How do you believe your attendance at this Symposium will help you improve your knowledge in the field and your professional development?
    • How do you consider that the findings published in your abstract make a relevant contribution to the topics presented during this Symposium?
    • Have you recently been awarded an ESMO travel grant? If yes, for which event?
  • A readable photocopy of either identity card or passport
  • A short curriculum vitae (maximum 2 pages)

Incomplete applications will not be considered. The outcome will be available on Friday, 17 October 2014.
The Immuno-Oncology Symposium Secretariat will provide the grant recipients with a travel subsidy, accommodation and Symposium registration. Grant recipients will be asked to submit a written report on their participation in the Sympoisum within four weeks after the event.


The Symposium webcasts will include all the session of the official programme, where speaker permission is granted, and will be available on this website and OncologyPro for ESMO members.